#202 y #203
Te lo explican, que veo que no lo has entendido.
https://www.prnewswire.com/news-releases/neuraltus-pharmaceuticals-reports-results-from-phase-2-np001-study-in-amyotrophic-lateral-sclerosis-als-300636633.html
https://www.neurologylive.com/conferences/aan-2018/np001-fails-to-meet-primary-secondary-endpoints-in-als-trial
#201 el estudio concluye que el medicamento huerfano detuvo la progresion de la enfermedad durante el tratamiento Conclusion: The arresting of progression of ALS symptoms by NP001 in a subset of patients with marked neuroinflammation, as observed here, will represent a novel therapeutic approach for patients with ALS, if confirmed.